ImageneBio, Inc. Form 4 Filing for Lu Yufang

Lu Yufang, Chief Medical Officer of ImageneBio, Inc., filed a Form 4 on August 7, 2025, reporting transactions on July 25, 2025. The filing details the acquisition of employee stock options following the merger of Inmagene Biopharmaceuticals with ImageneBio. The options include the right to buy shares of common stock at various exercise prices and expiration dates. The transactions involve 38,137 shares at $28.72, 27,459 shares at $4.59, 4,591 shares at $4.59, and 6,102 shares at $4.59. The filing was delayed due to issues obtaining the reporting person's EDGAR codes.